Retina Eye Center

04/07/2026

The Retina Eye Center makes it simple for healthcare providers to refer patients for specialized retina care. By submitting the online referral form, your patients will be promptly evaluated and supported by a team of experts dedicated to providing the highest level of care. Learn more: https://brnw.ch/21x1nJS

Thank you for trusting The Retina Eye Center with your patient's care. We look forward to providing you and your patients with exceptional care and support.

04/02/2026

March is Women’s Eye Health and Safety Month, a time to highlight the importance of protecting vision and prioritizing eye care. Women are at greater risk for certain eye conditions and vision changes, making regular eye exams essential for early detection and treatment. Prioritizing eye health is an important part of maintaining overall well-being.

03/30/2026

Happy National Doctors’ Day to our dedicated physicians who work tirelessly to protect and preserve our vision. Their expertise, compassion, and commitment make a lasting difference in the lives of our patients each day.

03/26/2026

Research shows that diabetes patients taking metformin may be less likely to develop intermediate age-related macular degeneration, highlighting potential vision-protecting benefits of this well-known medication. This breakthrough could pave the way for new, accessible AMD treatments. Learn more: https://brnw.ch/21x14z7

Metformin, a common diabetes medication, may be associated with less development of intermediate age-related macular degeneration (AMD).

03/24/2026

Your vision deserves expert, compassionate care. Our dedicated retina team works together to provide personalized treatment plans and a comfortable experience every step of the way. We’re proud to support our patients throughout their entire retinal health journey. Learn more: https://brnw.ch/21x10ji

03/19/2026

Clear vision starts with a healthy retina. Through detailed exams and state-of-the-art diagnostic testing, retinal conditions can be identified and monitored with precision. Early detection and consistent care make all the difference. Learn more: https://brnw.ch/21x0Se9

03/17/2026

A study warns that some commercially available red light therapy devices for myopia may exceed safety limits and risk retinal damage. Experts urge rigorous safety testing before widespread use, especially in children. Learn more: https://brnw.ch/21x0Ocp

Lab tests show red‑light myopia devices exceed ANSI safety limits in seconds, fueling urgent calls for independent validation before kids use them.

03/12/2026

New treatments for age-related macular degeneration (AMD) and diabetic macular edema (DME) can help manage fluid in the retina while allowing longer intervals between injections. Personalized care and regular check-ups help protect vision and achieve the best possible outcomes. Learn more: https://brnw.ch/21x0G8K

Strategies for treatment intervals, drug selection, and patient expectations.

03/10/2026

Uveitis is a form of eye inflammation that can affect important structures inside the eye and, if left untreated, may lead to vision loss. Early diagnosis and personalized treatment are key to protecting your sight and maintaining long-term eye health. Learn more: https://brnw.ch/21x0C1p

03/05/2026

Researchers discovered that Greenland sharks maintain healthy vision for centuries thanks to a unique DNA repair mechanism. Studying these long-lived animals may help scientists develop new ways to protect human vision and prevent age-related eye diseases. Learn more: https://brnw.ch/21x0tOF

Researchers uncover a DNA repair mechanism in Greenland sharks that preserves their vision for centuries, offering insights into longevity and eye health.

03/03/2026

A wet age-related macular degeneration diagnosis can feel overwhelming, but today’s advanced treatments and regular monitoring offer real hope for protecting your vision. With personalized care and consistent follow-ups, many patients are able to stabilize and even improve their sight. Learn more: https://brnw.ch/21x0pGZ

02/26/2026

Ocugen’s new gene therapy, OCU410, is showing promise in early trial results for treating geographic atrophy, a severe form of dry AMD. After 12 months, patients had slower disease progression with no serious side effects. A larger trial is expected in 2026. Learn more: https://brnw.ch/21x0hol

The trial is evaluating OCU410 (AAV5-RORA) for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration.